Multimodal MRI in Multiple Sclerosis (MS): Reliability and Follow Up

Groupe Hospitalier Pitie-Salpetriere

Overview

To determine wether multimodal MRI (conventinal T1 and T2 sequences, diffusion, magnetization transfer, spectroscopy) is reproducible; to follow up a cohort of patients with early remmittent MS after treatment with interferon.

Study Type

OBSERVATIONAL

Conditions

Multiple Sclerosis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * MS patients according to Poser's criteria * Remitting evolution (less than two years of evolution) * Aged 18-50 * Immunomodulatory treatment indicated Exclusion Criteria: * Unable to perform MRI

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.